Artificial Intelligence in Thoracic Radiation Oncology: Treatment, Challenges, and Future Directions
Grace Lee, MD+more
In part 2 of our look at AI’s impact on radiotherapy, Grace Lee, MD, Fridolin Haugg, MSc, and Raymond H. Mak, MD, discuss how AI may be leveraged when delivering radiotherapy, including improving our ability to predict treatment response and adverse events. Read more
IASLC Launches Multiple Initiatives as Work on its New Strategic Plan Begins
Erin JungmeyerProjects—including a team science grant, an expanded IASLC Academy, and an international biomarker survey—aim to help the association meet the needs of the global lung cancer community, IASLC leaders say. Read more
The European Commission recently approved adagrasib for KRAS G12C+ non-small cell lung cancer. Additionally, the US FDA has accepted a premarket approval application for tumor treating fields therapy. Read more
Abstract Submissions, Reviewer Workshop Applications Open for WCLC
Erin JungmeyerThe 2024 World Conference on Lung Cancer may still be months away, but with deadlines approaching, now is the time to submit scientific abstracts and applications for the JTO manuscript reviewer workshop. Read more
IASLC, LCRF Request Proposals for New Research Grant
Erin JungmeyerResearch teams with integrated projects focused on curing oncogene-driven lung cancers could receive up to $2.5 million over 4 years. Read more
Artificial Intelligence in Thoracic Radiation Oncology: Patient Evaluation and Treatment Planning
Grace Lee, MD+more
In part 1 of a 2-part article, Grace Lee, MD, Fridolin Haugg, MSc, and Raymond H. Mak, MD, explore the possibilities and limitations of AI applications. Read more
In an interview with ILCN, Drs. Puneeth Iyengar and Matthias Guckenberger said despite a lack of phase III data in this space, science-based recommendations are needed to optimize multimodal therapy. Read more
New Registry Aims to Expand Knowledge of Lung Cancer Treatment During Pregnancy
Erin JungmeyerDr. Narjust Florez, who is spearheading the effort at Dana Farber, says the need for research on cancer therapies for pregnant patients is urgent as both maternal age and the number of young lung cancer diagnoses are increasing. Read more
Screening Experts Outline Considerations for LDCT Screening Programs
Erin JungmeyerLead author Dr. Claudia Henschke says a recently published perspective from the IASLC Early Detection and Screening Committee explores several components of effective screening efforts, including timing between screenings. Read more
Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC
Famke L. Schneiders, MD, PhD+more
Drs. Famke L. Schneiders and Suresh Senan explore evidence that supports the use of radiotherapy to prime the immune system to maximize the benefits of immunotherapy. Read more